These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8467854)

  • 1. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats.
    Löscher W; Hönack D
    Eur J Pharmacol; 1993 Mar; 232(2-3):147-58. PubMed ID: 8467854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ucb L059, a novel anti-convulsant drug: pharmacological profile in animals.
    Gower AJ; Noyer M; Verloes R; Gobert J; Wülfert E
    Eur J Pharmacol; 1992 Nov; 222(2-3):193-203. PubMed ID: 1451732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy.
    Löscher W; Hönack D; Rundfeldt C
    J Pharmacol Exp Ther; 1998 Feb; 284(2):474-9. PubMed ID: 9454787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of SB-204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures.
    Upton N; Blackburn TP; Campbell CA; Cooper D; Evans ML; Herdon HJ; King PD; Ray AM; Stean TO; Chan WN; Evans JM; Thompson M
    Br J Pharmacol; 1997 Aug; 121(8):1679-86. PubMed ID: 9283703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-deprenyl (selegiline) exerts anticonvulsant effects against different seizure types in mice.
    Löscher W; Lehmann H
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1410-7. PubMed ID: 8667204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.
    Löscher W; Nolting B; Hönack D
    Eur J Pharmacol; 1988 Jul; 152(1-2):9-17. PubMed ID: 3061831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy.
    Borowicz KK; Luszczki JJ; Duda AM; Czuczwar SJ
    Epilepsia; 2003 May; 44(5):640-6. PubMed ID: 12752462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant effect of flutamide on seizures induced by pentylenetetrazole: involvement of benzodiazepine receptors.
    Ahmadiani A; Mandgary A; Sayyah M
    Epilepsia; 2003 May; 44(5):629-35. PubMed ID: 12752460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices.
    Löscher W; Nolting B
    Epilepsy Res; 1991; 9(1):1-10. PubMed ID: 1884714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
    Matagne A; Margineanu DG; Kenda B; Michel P; Klitgaard H
    Br J Pharmacol; 2008 Aug; 154(8):1662-71. PubMed ID: 18500360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
    Klitgaard H
    Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in rats.
    Coppola G; Arcieri S; D'Aniello A; Messana T; Verrotti A; Signoriello G; Pascotto A
    Seizure; 2010 Jun; 19(5):296-9. PubMed ID: 20399683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam.
    Kaminski RM; Gillard M; Leclercq K; Hanon E; Lorent G; Dassesse D; Matagne A; Klitgaard H
    Epilepsia; 2009 Jul; 50(7):1729-40. PubMed ID: 19486357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
    Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
    Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo.
    Margineanu DG; Wülfert E
    Eur J Pharmacol; 1995 Nov; 286(3):321-5. PubMed ID: 8608796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
    Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
    Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man.
    Matagne A; Klitgaard H
    Epilepsy Res; 1998 Jun; 31(1):59-71. PubMed ID: 9696301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AWD 140-190: a potent anticonvulsant in the amygdala-kindling model of partial epilepsy.
    Tober C; Löscher W; Hönack D; Bartsch R
    Epilepsia; 2001 May; 42(5):590-9. PubMed ID: 11380565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.